Exempting low-risk health and medical research from ethics reviews: comparing Australia, the United Kingdom, the United States and the Netherlands

Anna Mae Scott*, Simon Kolstoe, M. C. Ploem, Zoë Hammatt, Paul Glasziou

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    131 Downloads (Pure)

    Abstract

    Background: Disproportionate regulation of health and medical research contributes to research waste. Better understanding of exemptions of research from ethics review in different jurisdictions may help to guide modification of review processes and reduce research waste. Our aim was to identify examples of low-risk human health and medical research exempt from ethics reviews in Australia, the United Kingdom, the United States and the Netherlands. 

    Methods: We examined documents providing national guidance on research ethics in each country, including those authored by the National Health and Medical Research Council (Australia), National Health Service (United Kingdom), the Office for Human Research Protections (United States) and the Central Committee on Research Involving Humans (the Netherlands). Examples and types of research projects exempt from ethics reviews were identified, and similar examples and types were grouped together. 

    Results: Nine categories of research were exempt from ethics reviews across the four countries; these were existing data or specimen, questionnaire or survey, interview, post-marketing study, evaluation of public benefit or service programme, randomised controlled trials, research with staff in their professional role, audit and service evaluation, and other exemptions. Existing non-identifiable data and specimens were exempt in all countries. Four categories - evaluation of public benefit or service programme, randomised controlled trials, research with staff in their professional role, and audit and service evaluation - were exempted by one country each. The remaining categories were exempted by two or three countries. 

    Conclusions: Examples and types of research exempt from research ethics reviews varied considerably. Given the considerable costs and burdens on researchers and ethics committees, it would be worthwhile to develop and provide clearer guidance on exemptions, illustrated with examples, with transparent underpinning rationales.

    Original languageEnglish
    Article number11
    JournalHealth Research Policy and Systems
    Volume18
    Issue number1
    DOIs
    Publication statusPublished - 28 Jan 2020

    Keywords

    • exemption
    • health research
    • human
    • international variation
    • low-risk research
    • medical research
    • research committees
    • Research ethics
    • waste in research

    Fingerprint

    Dive into the research topics of 'Exempting low-risk health and medical research from ethics reviews: comparing Australia, the United Kingdom, the United States and the Netherlands'. Together they form a unique fingerprint.

    Cite this